Emmaus Life Sciences Inc (EMMA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 293 | 886 | 1,333 | 1,389 | 1,255 |
| Receivables | 2,619 | 2,071 | 2,061 | 2,623 | 4,992 |
| Inventories | 1,213 | 1,313 | 1,437 | 1,635 | 1,610 |
| TOTAL | $4,786 | $5,015 | $5,653 | $6,767 | $9,204 |
| Non-Current Assets | |||||
| PPE Net | 128 | 143 | 41 | 46 | 49 |
| Investments And Advances | 14,876 | 17,188 | 15,231 | 15,037 | 16,059 |
| Other Non-Current Assets | 966 | 998 | 1,553 | 1,752 | 2,031 |
| TOTAL | $15,970 | $18,329 | $16,825 | $16,835 | $18,139 |
| Total Assets | $20,756 | $23,344 | $22,478 | $23,602 | $27,343 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | 16,864 | N/A | N/A |
| Accounts payable and accrued liabilities | 21,759 | 19,373 | 18,313 | 16,926 | 18,707 |
| Other current liabilities | 14,486 | 14,152 | 16,420 | 16,565 | 16,203 |
| TOTAL | $64,169 | $62,076 | $64,915 | $63,555 | $64,131 |
| Non-Current Liabilities | |||||
| Long Term Debt | 2,264 | 2,257 | 2,251 | 2,246 | 2,241 |
| Other Non-Current Liabilities | 13,811 | 14,712 | 13,913 | 14,280 | 14,752 |
| TOTAL | $16,075 | $16,969 | $16,164 | $16,526 | $16,993 |
| Total Liabilities | $80,244 | $79,045 | $81,079 | $80,081 | $81,124 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 63,866 | 63,866 | 63,866 | 63,866 | 63,866 |
| Common Shares | 64 | 64 | 64 | 64 | 64 |
| Retained earnings | -268,116 | -266,040 | -264,905 | -262,575 | -260,827 |
| Other shareholders' equity | -17,350 | -15,630 | -19,666 | -19,864 | -18,885 |
| TOTAL | $-59,488 | $-55,701 | $-58,601 | $-56,479 | $-53,781 |
| Total Liabilities And Equity | $20,756 | $23,344 | $22,478 | $23,602 | $27,343 |